Transcriptomics

Dataset Information

0

Gene expression profiling of effect of Yap inhibition in a genetically engineered mouse model of hepatocellular carcinoma


ABSTRACT: Defective Hippo/YAP signaling in the liver results in tissue overgrowth and development of hepatocellular carcinoma (HCC). Here, we uncover mechanisms of YAP-mediated hepatocyte reprogramming and HCC pathogenesis. We show that YAP functions as a rheostat maintaining metabolic specialization, differentiation and quiescence within the hepatocyte compartment. Importantly, treatment with siRNA-lipid nanoparticles (siRNA-LNPs) targeting YAP restores hepatocyte differentiation and causes pronounced tumor regression in a genetically engineered mouse HCC model (mice with liver-specific Mst1/Mst2 double knockout). Furthermore, YAP targets are enriched in an aggressive human HCC subtype characterized by a proliferative signature and absence of CTNNB1 mutations. Thus, our work reveals Hippo signaling as a key regulator of positional identity of hepatocytes, supports targeting YAP using siRNA-LNPs as a paradigm of differentiation-based therapy, and identifies an HCC subtype potentially responsive to this approach.

ORGANISM(S): Mus musculus

PROVIDER: GSE65665 | GEO | 2015/03/07

SECONDARY ACCESSION(S): PRJNA274661

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2015-03-07 | E-GEOD-65665 | biostudies-arrayexpress
2014-01-02 | E-GEOD-50219 | biostudies-arrayexpress
2014-01-02 | GSE50219 | GEO
2015-01-01 | E-GEOD-61582 | biostudies-arrayexpress
2020-04-18 | GSE144776 | GEO
2024-02-26 | GSE248501 | GEO
2015-01-01 | GSE61582 | GEO
2020-05-24 | GSE144579 | GEO
2020-05-24 | GSE144578 | GEO
2020-05-24 | GSE144577 | GEO